Literature DB >> 24442402

Radiologic and histologic consequences of radiosurgery for brain tumors.

Ahmed Alomari1, Philipp J Rauch, Maria Orsaria, Frank J Minja, Veronica L Chiang, Alexander O Vortmeyer.   

Abstract

Progressively enlarging encephalopathic changes are now well-documented effects of gamma knife radiosurgery (GKRS) occurring ~3-30 months after treatment of both benign and malignant brain lesions. These changes can be variably associated with inflammatory demyelination and necrosis and/or recurrent tumor. While radiographic differentiation between encephalopathic changes and recurrent tumor is of high clinical relevance, confident interpretation of post-radiosurgery imaging changes can be challenging or even impossible in some cases. Gadolinium-enhanced MRI of these lesions reveals variable amounts of enhancing and non-enhancing components within these lesions that have not been clearly correlated with structural-pathologic change. The goal of this study is to characterize the histopathological changes associated with enhancing versus non-enhancing regions of GKRS-treated lesions. MRI images of patients with progressive, etiologically ambiguous brain lesions following GKRS were reviewed prior to explorative neurosurgery. Chosen for this study were lesions in which distinct areas of enhancement and non-enhancement of at least 5 mm in size could be identified (n = 16). Distinctly enhancing and non-enhancing areas were separately biopsied and histologically evaluated. Only cases with uniform histological results are presented in this study. Enhancing and non-enhancing areas in post GKRS lesions represent separate pathological changes. Radiographically enhancing areas correlate either with recurrent tumor growth or inflammatory demyelinating changes. Lack of radiographic enhancement correlates with coagulative necrosis if the sample is taken from the center of the lesion, or with reactive astrocytosis if the sample is taken from the periphery. Separate biopsy of enhancing and non-enhancing regions of post-GKRS encephalopathy was able to confirm that the pathologies in these areas are distinct. These findings allow for better-informed correlation of histological and radiological changes and a better understanding of post-treatment tissue pathology.

Entities:  

Mesh:

Year:  2014        PMID: 24442402     DOI: 10.1007/s11060-014-1359-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

Review 1.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

Authors:  Soonmee Cha; Edmond A Knopp; Glyn Johnson; Stephan G Wetzel; Andrew W Litt; David Zagzag
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

Review 2.  Toward an expanded view of radiosurgery.

Authors:  John R Adler; Federico Colombo; M Peter Heilbrun; Ken Winston
Journal:  Neurosurgery       Date:  2004-12       Impact factor: 4.654

Review 3.  Management of ruptured brain arteriovenous malformations.

Authors:  Brad E Zacharia; Kerry A Vaughan; Adam Jacoby; Zachary L Hickman; Daniel Bodmer; E Sander Connolly
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

4.  MR of brain radiation injury: experimental studies in cats.

Authors:  C Hecht-Leavitt; R I Grossman; W J Curran; J T McGrath; D N Biery; P M Joseph; D F Nelson
Journal:  AJNR Am J Neuroradiol       Date:  1987 May-Jun       Impact factor: 3.825

5.  Long-term outcomes after meningioma radiosurgery: physician and patient perspectives.

Authors:  D Kondziolka; E I Levy; A Niranjan; J C Flickinger; L D Lunsford
Journal:  J Neurosurg       Date:  1999-07       Impact factor: 5.115

6.  Histopathology of brain metastases after radiosurgery.

Authors:  György T Szeifert; Douglas Kondziolka; Marc Levivier; L Dade Lunsford
Journal:  Prog Neurol Surg       Date:  2012-01-06

7.  Delayed radiation-induced vasculitic leukoencephalopathy.

Authors:  Philipp J Rauch; Henry S Park; Jonathan P S Knisely; Veronica L Chiang; Alexander O Vortmeyer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-10-22       Impact factor: 7.038

8.  In vivo visualization of reactive gliosis using manganese-enhanced magnetic resonance imaging.

Authors:  Yuko Kawai; Ichio Aoki; Masahiro Umeda; Toshihiro Higuchi; Jeff Kershaw; Makoto Higuchi; Afonso C Silva; Chuzo Tanaka
Journal:  Neuroimage       Date:  2009-11-10       Impact factor: 6.556

9.  Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.

Authors:  D Kahn; K A Follett; D L Bushnell; M A Nathan; J G Piper; M Madsen; P T Kirchner
Journal:  AJR Am J Roentgenol       Date:  1994-12       Impact factor: 3.959

10.  Radiation effects on cerebral white matter: MR evaluation.

Authors:  J S Tsuruda; K E Kortman; W G Bradley; D C Wheeler; W Van Dalsem; T P Bradley
Journal:  AJR Am J Roentgenol       Date:  1987-07       Impact factor: 3.959

View more
  17 in total

Review 1.  The biology of radiosurgery and its clinical applications for brain tumors.

Authors:  Douglas Kondziolka; Samuel M Shin; Andrew Brunswick; Irene Kim; Joshua S Silverman
Journal:  Neuro Oncol       Date:  2014-09-28       Impact factor: 12.300

2.  CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment.

Authors:  Yonghao Cao; Alyssa Nylander; Sriram Ramanan; Brittany A Goods; Gerald Ponath; Rana Zabad; Veronica L S Chiang; Alexander O Vortmeyer; David A Hafler; David Pitt
Journal:  Neurology       Date:  2016-03-16       Impact factor: 9.910

3.  Computer-based radiological longitudinal evaluation of meningiomas following stereotactic radiosurgery.

Authors:  Eli Ben Shimol; Leo Joskowicz; Ruth Eliahou; Yigal Shoshan
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-10-14       Impact factor: 2.924

4.  Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experience.

Authors:  Isabela Peña Pino; Jun Ma; Yusuke S Hori; Elena Fomchenko; Kathryn Dusenbery; Margaret Reynolds; Christopher Wilke; Jianling Yuan; Ethan Srinivasan; Matthew Grabowski; Peter Fecci; Evidio Domingo-Musibay; Naomi Fujioka; Gene H Barnett; Veronica Chang; Alireza M Mohammadi; Clark C Chen
Journal:  J Neurooncol       Date:  2022-01-10       Impact factor: 4.130

5.  Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China.

Authors:  Yang Wang; Bin Lian; Lu Si; ZhiHong Chi; XiNan Sheng; Xuan Wang; LiLi Mao; BiXia Tang; SiMing Li; XieQiao Yan; Xue Bai; Li Zhou; ChuanLiang Cui; Jun Guo
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-21       Impact factor: 4.553

6.  Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.

Authors:  Sarah B Goldberg; Scott N Gettinger; Amit Mahajan; Anne C Chiang; Roy S Herbst; Mario Sznol; Apostolos John Tsiouris; Justine Cohen; Alexander Vortmeyer; Lucia Jilaveanu; James Yu; Upendra Hegde; Stephanie Speaker; Matthew Madura; Amanda Ralabate; Angel Rivera; Elin Rowen; Heather Gerrish; Xiaopan Yao; Veronica Chiang; Harriet M Kluger
Journal:  Lancet Oncol       Date:  2016-06-03       Impact factor: 41.316

7.  Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.

Authors:  Jay S Detsky; Julia Keith; John Conklin; Sean Symons; Sten Myrehaug; Arjun Sahgal; Chinthaka C Heyn; Hany Soliman
Journal:  J Neurooncol       Date:  2017-07-03       Impact factor: 4.130

8.  Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis.

Authors:  Jeffrey P Guenette; Raymond Y Huang; Pyeong Hwa Kim; Chong Hyun Suh; Ho Sung Kim; Kyung Won Kim; Dong Yeong Kim; Ayal A Aizer; Rifaquat Rahman
Journal:  Eur Radiol       Date:  2020-11-25       Impact factor: 5.315

9.  Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot Study.

Authors:  Akash Deelip Shah; Amaresha Shridhar Konar; Ramesh Paudyal; Jung Hun Oh; Eve LoCastro; David Aramburu Nuñez; Nathaniel Swinburne; Behroze Vachha; Gary A Ulaner; Robert J Young; Andrei I Holodny; Kathryn Beal; Amita Shukla-Dave; Vaios Hatzoglou
Journal:  J Neuroimaging       Date:  2020-12-28       Impact factor: 2.486

10.  Detection of residual metastatic tumor in the brain following Gamma Knife radiosurgery using a single or a series of magnetic resonance imaging scans: An autopsy study.

Authors:  Madoka Sakuramachi; Hiroshi Igaki; Masako Ikemura; Hideomi Yamashita; Kae Okuma; Noriyasu Sekiya; Yayoi Hayakawa; Akira Sakumi; Wataru Takahashi; Hirotaka Hasegawa; Masashi Fukayama; Keiichi Nakagawa
Journal:  Oncol Lett       Date:  2017-06-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.